Medical management of children with primary hypertension by pediatric subspecialists.
Our aim was to characterize medical management of children with primary hypertension (HTN) by pediatric subspecialists. We performed a medical-record review of children < or = 18 years with primary HTN seen at pediatric cardiology or pediatric nephrology clinics at an academic center. Main outcomes were whether treatment decision was in agreement with national guidelines, whether an antihypertensive medication was prescribed, and medication choice. One hundred and eighty children had > or = 1 visit to a pediatric cardiology or nephrology clinic. The majority (83%) of children were pharmacologically managed according to national guidelines. However, only 1/3 children with stage 2 HTN received appropriate antihypertensive therapy from either subspecialty. Only 26 children were prescribed an antihypertensive drug. Children evaluated by pediatric nephrologists were fourfold more likely to receive an antihypertensive than children seen by pediatric cardiologists (29% vs. 7%; p < 0.001). However, all antihypertensive prescriptions were prescribed according to guidelines by both subspecialties. Medical management of children with primary HTN by pediatric cardiologists and pediatric nephrologists is largely consistent with guidelines. However, initiation of appropriate antihypertensive drugs for children with highest severity of HTN is equally poor for both subspecialties. Future studies should explore the factors underlying physicians' reluctance to initiate recommended chronic pharmacologic therapy in children and its associated outcomes.
Yoon
Esther Y
EY
Division of General Pediatrics, University of Michigan, 300 North Ingalls Building 6E07, Ann Arbor, MI, 48109-5456, USA. est@med.umich.edu
Davis
Matthew M
MM
Rocchini
Albert
A
Kershaw
David
D
Freed
Gary L
GL
D000046:Academic Medical Centers; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002648:Child; D017408:Guidelines as Topic; D006776:Hospitals, Pediatric; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008499:Medical Records; D009398:Nephrology / Q000379:methods*; D010372:Pediatrics / Q000379:methods*; D010818:Practice Patterns, Physicians'
D000959:Antihypertensive Agents
Arch Pediatr Adolesc Med. 2000 Jul;154(7):685-93
10891020
Arch Pediatr Adolesc Med. 2001 Sep;155(9):1057-62
11529809
J Pediatr. 1999 Jun;134(6):668-74
10356132
Pediatrics. 2004 Dec;114(6):1534-44
15574612
Pediatr Ann. 2001 May;30(5):274-82
11383467
Pediatrics. 1998 Mar;101(3 Pt 1):349-54
9480996
JAMA. 2007 Aug 22;298(8):874-9
17712071
Pediatrics. 1999 Apr;103(4 Pt 1):711-8
10103291
Med Care. 1998 Nov;36(11):1567-77
9821944
JAMA. 1999 Oct 20;282(15):1458-65
10535437
Arch Pediatr Adolesc Med. 2002 Feb;156(2):141-6
11814375
Pediatrics. 2008 Jul;122(1):198-208
18596007
Pediatr Nephrol. 2005 Jun;20(6):791-7
15809834
Pediatrics. 1979 Jan;63(1):32-6
440800
Pediatrics. 2000 Oct;106(4 Suppl):886-96
11044140
J Pediatr. 1989 Apr;114(4 Pt 1):664-9
2784501
Pediatrics. 2004 Aug;114(2 Suppl 4th Report):555-76
15286277
Med Care Res Rev. 2005 Oct;62(5):544-59
16177457
Ann Emerg Med. 2003 Dec;42(6):835-42
14634611
JAMA. 2002 Dec 18;288(23):2981-97
12479763
Health Serv Res. 2005 Oct;40(5 Pt 1):1443-65
16174142
J Pediatr. 2007 Jun;150(6):640-4, 644.e1
17517252
J Pediatr. 2003 Oct;143(4):413-4
14571208
JAMA. 2005 Apr 27;293(16):1995-2002
15855433
CMAJ. 2003 Sep 2;169(5):405-12
12952801
Pediatrics. 2003 Mar;111(3):e214-20
12612274
Arch Intern Med. 2003 Jul 28;163(14):1673-81
12885682
Can Med Assoc J. 1975 Jul 26;113(2):103-8
124624
Chest. 1999 Oct;116(4 Suppl 1):154S-162S
10532477